Evidence map›Paper›PMID 42123506›Full record

ArticleInternational journal of molecular sciences2026

Preservation of Extracellular and Tissue Dopamine During Tyrosine Hydroxylase Loss in Rat 6-OHDA Parkinson's Model: Selective Compensation Restricted to Substantia Nigra.

Ashley Galfano, Robert McManus, Walter Navarrete, Sampada Chaudhari, Christopher Bishop, Michael F Salvatore

Abstract read
In one paragraph

Article in International journal of molecular sciences, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Ashley GalfanoDepartment of Psychology, Binghamton University, Binghamton, NY 13902, USA.
Robert McManusDepartment of Pharmacology and Neuroscience, University of North Texas Health Science Center Fort Worth, Fort Worth, TX 76107, USA.ORCID 0000-0002-0465-0129
Walter NavarreteDepartment of Pharmacology and Neuroscience, University of North Texas Health Science Center Fort Worth, Fort Worth, TX 76107, USA.
Sampada ChaudhariDepartment of Pharmacology and Neuroscience, University of North Texas Health Science Center Fort Worth, Fort Worth, TX 76107, USA.
Christopher BishopDepartment of Psychology, Binghamton University, Binghamton, NY 13902, USA.ORCID 0000-0003-4623-1085
Michael F SalvatoreDepartment of Pharmacology and Neuroscience, University of North Texas Health Science Center Fort Worth, Fort Worth, TX 76107, USA.ORCID 0000-0003-0217-5093

Funding

United States Department of Defense W81XWH-19-1-0757
6 · The paper itself

Abstract

Compensatory mechanisms are thought to maintain sufficient dopamine (DA) signaling to mitigate locomotor impairment during progressive nigrostriatal neuron loss in Parkinson's disease (PD). Recent evidence indicated augmented DA tissue content in the substantia nigra (SN), not striatum, compensates for tyrosine hydroxylase (TH) and neuronal loss, and alleviates the severity of hypokinesia during neuronal loss. Here, we determined if increased extracellular DA in the SN may also be a compensatory mechanism to augment DA signaling. Following unilateral 6-hydroxydopamine (6-OHDA) lesion or sham-operation, we contemporaneously evaluated extracellular DA against both DA tissue and TH levels in striatum and SN at 7 and 28 days. At 7 days post-lesion, TH loss exceeded ~90% in striatum, and ~70% in the SN. The severity of DA tissue loss coincided with TH protein loss only in striatum (>90%) on both days after lesion, whereas in the SN, DA loss was absent on day 7 and significantly less than TH loss by day 28. Whereas there was a robust increase in extracellular DA in striatum in our sham-operation group, the severe TH and DA tissue loss in striatum practically abolished KCl (K

Indexed as

Corpus StriatumDopamineParkinson DiseaseSubstantia NigraTyrosine 3-MonooxygenaseAnimalsDisease Models, AnimalExtracellular FluidFemaleMaleRatsRats, Sprague-DawleySex CharacteristicsDopamineTyrosine 3-MonooxygenasedopamineParkinson’s diseasestriatumsubstantia nigratyrosine hydroxylase

Identifiers

PMID42123506
PMCPMC13163906

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.